tiprankstipranks
Trending News
More News >
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market

Oncotelic Therapeutics (OTLC) Income Statement

Compare
86 Followers

Oncotelic Therapeutics Income Statement

Last quarter (Q3 2025), Oncotelic Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Oncotelic Therapeutics's net income was $-1.05M. See Oncotelic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 70.00K$ 0.00$ 0.00$ 1.74M
Gross Profit
$ 0.00$ 70.00K$ -12.84K$ -61.51K$ 1.74M
Operating Expenses
$ 376.01K$ 6.72M$ 5.61M$ 9.13M$ 9.33M
Depreciation and Amortization
$ 376.01K$ 12.84K$ 12.84K$ 61.51K$ 364.21K
EBITDA
$ -3.55M$ -7.16M$ -5.60M$ -9.06M$ -7.61M
Operating Income
$ -3.58B$ -6.65M$ -9.72M$ -9.13M$ -7.58M
Other Income/Expenses
$ -947.92M$ -1.56M$ 14.40M$ -1.39M$ -2.39M
Pretax Income
$ -4.52B$ -8.21M$ 4.68M$ -10.52M$ -9.97M
Net Income
$ -4.52B$ -7.90M$ 17.82M$ -11.39M$ -11.50M
Per Share Metrics
Basic EPS
$ -0.01$ -0.02$ 0.05$ -0.04$ -0.13
Diluted EPS
$ -0.01$ -0.02$ 0.04$ -0.04$ -0.13
Weighted Average Shares Outstanding
404.40M 396.17M 384.08M 303.08M 88.10M
Weighted Average Shares Outstanding (Diluted)
404.40M 396.17M 457.30M 303.08M 88.10M
Currency in USD

Oncotelic Therapeutics Earnings and Revenue History